Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aravinda Pai

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
3 Biotech|September 6, 2022
Novel benzylidene benzofuranone analogues as potential anticancer agents: design, synthesis and in vitro evaluation based on CDK2 inhibition assaysAravinda Pai, Jayashree B S
Molecular Diversity|November 24, 2017
Application of two-dimensional binary fingerprinting methods for the design of selective Tankyrase I inhibitorsB S Muddukrishna, Vasudev Pai, Richard Lobo, et al.
Journal of Molecular Graphics & Modelling|January 9, 2017
Novel flavonol analogues as potential inhibitors of JMJD3 histone demethylase-A study based on molecular modellingSanchari Basu Mallik, Aravinda Pai, Rekha R Shenoy, et al.
BMC Complementary and Alternative Medicine|October 29, 2014
Cytotoxic potential of Anisochilus carnosus (L.f.) wall and estimation of luteolin content by HPLCJaykumar Bhagat, Richard Lobo, Nimmy Kumar, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 5, 2023
Calixarenes and their Relevance in Anticancer Drug DevelopmentSoumyajeet Paul, Ramaiah Selladurai Jeyaprakash, Aravinda Pai, et al.
Bioorganic Chemistry|October 7, 2024
Advances in designing ternary complexes: Integrating in-silico and biochemical methods for PROTAC optimisation in target protein degradationShareef Shaik, Prasanna Kumar Reddy Gayam, Manish Chaudhary, et al.
3 Biotech|September 1, 2021
In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophyAbhishek Shah, Aarti Abhishek Shah, Krishnadas Nandakumar, et al.
RSC Advances|December 8, 2025
Computational design, synthesis, <i>in vitro</i> and <i>in vivo</i> evaluation of a 3,4-methylenedioxyphenol (sesamol) derivative as an NRF2/HO-1 pathway activator for protection against drug-induced liver injuryAjay Mili, Sumit Birangal, Krishnadas Nandakumar, et al.
Bioorganic & Medicinal Chemistry|August 29, 2025
Targeting Alzheimer's pathology: Tetralone- and thiochromanone-based benzyl pyridinium derivatives as promising multi-target-directed ligandsAnjali Sobha, Lekshmy Krishnan, Shareef Shaik, et al.
ACS Chemical Neuroscience|September 22, 2025
Multi-Target-Directed Triazole Derivatives: Design, Synthesis, and Evaluation of Synergistic Modulation in Alzheimer's DiseaseAnjali Sobha, Lekshmy Krishnan, Sreelakshmi Vijayakumar, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
3 Biotech|September 6, 2022
Novel benzylidene benzofuranone analogues as potential anticancer agents: design, synthesis and in vitro evaluation based on CDK2 inhibition assaysAravinda Pai, Jayashree B S
Molecular Diversity|November 24, 2017
Application of two-dimensional binary fingerprinting methods for the design of selective Tankyrase I inhibitorsB S Muddukrishna, Vasudev Pai, Richard Lobo, et al.
Journal of Molecular Graphics & Modelling|January 9, 2017
Novel flavonol analogues as potential inhibitors of JMJD3 histone demethylase-A study based on molecular modellingSanchari Basu Mallik, Aravinda Pai, Rekha R Shenoy, et al.
BMC Complementary and Alternative Medicine|October 29, 2014
Cytotoxic potential of Anisochilus carnosus (L.f.) wall and estimation of luteolin content by HPLCJaykumar Bhagat, Richard Lobo, Nimmy Kumar, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 5, 2023
Calixarenes and their Relevance in Anticancer Drug DevelopmentSoumyajeet Paul, Ramaiah Selladurai Jeyaprakash, Aravinda Pai, et al.
Bioorganic Chemistry|October 7, 2024
Advances in designing ternary complexes: Integrating in-silico and biochemical methods for PROTAC optimisation in target protein degradationShareef Shaik, Prasanna Kumar Reddy Gayam, Manish Chaudhary, et al.
3 Biotech|September 1, 2021
In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophyAbhishek Shah, Aarti Abhishek Shah, Krishnadas Nandakumar, et al.
RSC Advances|December 8, 2025
Computational design, synthesis, <i>in vitro</i> and <i>in vivo</i> evaluation of a 3,4-methylenedioxyphenol (sesamol) derivative as an NRF2/HO-1 pathway activator for protection against drug-induced liver injuryAjay Mili, Sumit Birangal, Krishnadas Nandakumar, et al.
Bioorganic & Medicinal Chemistry|August 29, 2025
Targeting Alzheimer's pathology: Tetralone- and thiochromanone-based benzyl pyridinium derivatives as promising multi-target-directed ligandsAnjali Sobha, Lekshmy Krishnan, Shareef Shaik, et al.
ACS Chemical Neuroscience|September 22, 2025
Multi-Target-Directed Triazole Derivatives: Design, Synthesis, and Evaluation of Synergistic Modulation in Alzheimer's DiseaseAnjali Sobha, Lekshmy Krishnan, Sreelakshmi Vijayakumar, et al.
Pageof 2